Analystreport

Novelion Therapeutics Inc (NASDAQ: NVLN) had its "hold" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $5.00 price target on the stock.

NOVELION THERAPEUTICS INC COMMON SHARES  (NVLN) 
Last novelion therapeutics inc common shares earnings: 5/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novelion.com